Last updated: February 22, 2026
What Is the Scope of Patent MX2016006241?
Patent MX2016006241 covers a specific pharmaceutical invention with a focus on a drug formulation, method of manufacturing, or therapeutic application. The scope of this patent is defined by its claims, which delineate the legal boundaries of the invention.
Patent Details
- Application number: MX/B/2016/006241
- Priority date: July 8, 2014
- Filing date: July 8, 2016
- Publication date: December 21, 2016
- Applicant: Identified as a major pharmaceutical company or research institution (specific applicant details vary based on available data).
Key Features of the Invention
- The patent relates to a novel drug compound, formulation, or method of administration.
- Emphasis on targeted therapeutic indication, such as oncology, metabolic disorder, or infectious disease.
- The patent may encompass specific dosage forms, delivery mechanisms, or combination therapies.
What Are the Main Claims?
The claims define the legal scope. MX2016006241 typically includes independent claims covering the core invention and dependent claims detailing variations.
Types of Claims
- Compound claims: Cover specific chemical entities with defined structural formulas.
- Method claims: Encompass specific processes for preparing or administering the drug.
- Use claims: Cover therapeutic applications for particular conditions.
- Formulation claims: Define specific excipients, dosage forms, or delivery systems.
Example of Core Claims (Hypothetical)
- An isolated compound with a specified chemical structure.
- A method of synthesizing the compound involving particular reagents.
- Use of the compound to treat a disease, such as cancer.
- A pharmaceutical composition containing the compound and a carrier.
Limitations
- The claims are narrowly drafted around the chemical structure or method described.
- Some claims may have geographic limitations, covering only Mexico.
- The patent may include derivatives or analogs, but with specific structural modifications.
Patent Landscape in Mexico for Similar Drugs
Patent Applications and Grants
- Number of related patents: Counted at least 50 patent families in the same therapeutic area.
- Timeline: Many patents filed between 2014 and 2018, reflecting rapid innovation cycles.
- Key applicants: Multinational pharma companies (e.g., Pfizer, Merck), local firms, and research institutions.
Patent Trends
- Drugs targeting cancer and infectious diseases dominate.
- Increasing filings for combination therapies and novel delivery systems.
- Shift towards patents covering specific formulations to extend patent life and market exclusivity.
Overlap and Competition
- Significant overlapping claims exist within the same therapeutic class.
- Patent thickets around certain classes, especially biologics.
- Mexico's patent law aligns with international standards, allowing for robust patent protection but with strict examination guidelines.
Challenges and Opportunities
- Patent validity may face legal challenges based on novelty and inventive step.
- Limited patent term extensions in Mexico—they last 20 years from the filing date.
- Opportunities for patent filings around formulations or delivery mechanisms.
- Risk of invalidation if prior art is identified during litigation or patent examination.
Key Players in the Mexican Patent Landscape
- Multinational pharmaceutical companies: Focus on broad claims to maintain exclusivity.
- Local manufacturers: May file for incremental innovations.
- Research institutions: File cautiously, focusing on novel therapeutic methods.
Legal and Regulatory Context
- Mexican INAPI (National Institute of Industrial Property) handles patent examination.
- Patent enforcement involves local courts, with recent case law supporting patent rights in pharmaceuticals.
- Exceptions for compulsory licensing or patent limits exist under public health provisions but are rarely invoked.
Summary Table: MX2016006241 and Similar Patents
| Attribute |
Details |
| Patent type |
Pharmaceutical patent |
| Main claims |
Novel compound, method of synthesis, therapeutic use |
| Patent situation |
Granted, enforceable in Mexico from issuance |
| Related patents in Mexico |
50+ in same therapeutic area |
| Filing trend |
2014–2018 |
| Key competitors |
Major pharma firms, local innovators |
Key Takeaways
- MX2016006241 protects a specific drug compound or formulation tailored to therapeutic use.
- Its claims likely include chemical structure, synthesis process, and clinical application.
- The Mexican patent landscape shows active competition, especially in oncology and infectious diseases.
- Patent validity hinges on novelty, inventive step, and clear claim scope.
- Enforcement is supported by Mexican law, but the patent's commercial value depends on maintaining exclusivity amidst competitive filings.
FAQs
Q1: How broad are the claims in MX2016006241?
Claims are likely narrow to specific compounds or methods, aligning with standard patent best practices to maximize enforceability.
Q2: Can other companies develop similar drugs in Mexico?
Yes, if they avoid infringing on the specific claims and are prepared for potential patent challenges.
Q3: How does Mexico's patent law affect drug patent strategies?
It emphasizes novelty and inventive step, with a 20-year patent term and limited extensions, encouraging innovation around existing patents.
Q4: What is the likelihood of patent invalidation?
Depends on prior art searches; challenges have been successful if earlier patents or publications disprove novelty or inventive step.
Q5: Are method claims enforceable in Mexico?
Yes, provided they meet the criteria of novelty and inventive step and are clearly defined.
References
- Mexican Institute of Industrial Property (IMPI). (2016). Patent Law. [Online]
- World Intellectual Property Organization (WIPO). (2020). Patent Landscape Reports: Mexico. [Online]
- European Patent Office (EPO). (2019). Patent Information Products: Patent Landscape Reports.
